

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to gravity (GO:0009629) | 6.46682461 |
| 2 | cytidine deamination (GO:0009972) | 6.19726539 |
| 3 | cytidine metabolic process (GO:0046087) | 6.19726539 |
| 4 | cytidine catabolic process (GO:0006216) | 6.19726539 |
| 5 | DNA deamination (GO:0045006) | 5.70238756 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.24263262 |
| 7 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.13490953 |
| 8 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.75577775 |
| 9 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.52115656 |
| 10 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.41976324 |
| 11 | sequestering of actin monomers (GO:0042989) | 4.34770619 |
| 12 | protein maturation by protein folding (GO:0022417) | 4.13494770 |
| 13 | actin nucleation (GO:0045010) | 4.10270157 |
| 14 | regulation of skeletal muscle contraction (GO:0014819) | 4.06371079 |
| 15 | negative regulation of muscle hypertrophy (GO:0014741) | 3.98618743 |
| 16 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.95613047 |
| 17 | eosinophil chemotaxis (GO:0048245) | 3.88787784 |
| 18 | ATP synthesis coupled proton transport (GO:0015986) | 3.85651608 |
| 19 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.85651608 |
| 20 | protein neddylation (GO:0045116) | 3.79123377 |
| 21 | response to interferon-beta (GO:0035456) | 3.72039190 |
| 22 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.70990697 |
| 23 | regulation of interleukin-8 secretion (GO:2000482) | 3.67683163 |
| 24 | respiratory electron transport chain (GO:0022904) | 3.64057550 |
| 25 | electron transport chain (GO:0022900) | 3.62298190 |
| 26 | platelet dense granule organization (GO:0060155) | 3.61002299 |
| 27 | skeletal muscle adaptation (GO:0043501) | 3.58085202 |
| 28 | skeletal muscle tissue regeneration (GO:0043403) | 3.55820315 |
| 29 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.53343229 |
| 30 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.50824476 |
| 31 | eosinophil migration (GO:0072677) | 3.48272659 |
| 32 | striated muscle atrophy (GO:0014891) | 3.39846572 |
| 33 | muscle filament sliding (GO:0030049) | 3.29591708 |
| 34 | actin-myosin filament sliding (GO:0033275) | 3.29591708 |
| 35 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.26681825 |
| 36 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.25359478 |
| 37 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.23650809 |
| 38 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.20435596 |
| 39 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.20435596 |
| 40 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.16211237 |
| 41 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.13932014 |
| 42 | muscle atrophy (GO:0014889) | 3.13035718 |
| 43 | membrane budding (GO:0006900) | 3.12447006 |
| 44 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.11046958 |
| 45 | negative regulation of T cell apoptotic process (GO:0070233) | 3.09887517 |
| 46 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.08074913 |
| 47 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.08074913 |
| 48 | signal peptide processing (GO:0006465) | 3.07973336 |
| 49 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.05750631 |
| 50 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.02860301 |
| 51 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.02860301 |
| 52 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.02860301 |
| 53 | negative regulation of viral genome replication (GO:0045071) | 2.95801917 |
| 54 | macrophage chemotaxis (GO:0048246) | 2.95075310 |
| 55 | protein complex biogenesis (GO:0070271) | 2.92563280 |
| 56 | response to testosterone (GO:0033574) | 2.92161293 |
| 57 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.89498691 |
| 58 | viral protein processing (GO:0019082) | 2.88271954 |
| 59 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.87173267 |
| 60 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.87173267 |
| 61 | proteasome assembly (GO:0043248) | 2.83229293 |
| 62 | negative regulation of membrane potential (GO:0045837) | 2.82426131 |
| 63 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.81994359 |
| 64 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.81836193 |
| 65 | negative regulation of ligase activity (GO:0051352) | 2.81836193 |
| 66 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.80756124 |
| 67 | purine nucleotide salvage (GO:0032261) | 2.80613443 |
| 68 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.78912641 |
| 69 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.77221140 |
| 70 | response to muscle activity (GO:0014850) | 2.75719524 |
| 71 | positive regulation of protein homodimerization activity (GO:0090073) | 2.73634839 |
| 72 | mannosylation (GO:0097502) | 2.73153696 |
| 73 | regulation of chronic inflammatory response (GO:0002676) | 2.72921960 |
| 74 | cellular response to zinc ion (GO:0071294) | 2.72626931 |
| 75 | GPI anchor biosynthetic process (GO:0006506) | 2.69484473 |
| 76 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.68070605 |
| 77 | GTP biosynthetic process (GO:0006183) | 2.66998542 |
| 78 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.66696747 |
| 79 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.66015506 |
| 80 | positive regulation of actin filament depolymerization (GO:0030836) | 2.63028847 |
| 81 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.60640270 |
| 82 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.60370042 |
| 83 | mature B cell differentiation (GO:0002335) | 2.60000775 |
| 84 | GPI anchor metabolic process (GO:0006505) | 2.59378628 |
| 85 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.58221824 |
| 86 | actin-mediated cell contraction (GO:0070252) | 2.58147750 |
| 87 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.57552997 |
| 88 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.56011930 |
| 89 | negative regulation by host of viral transcription (GO:0043922) | 2.55461096 |
| 90 | negative regulation of stress fiber assembly (GO:0051497) | 2.55121677 |
| 91 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.54855827 |
| 92 | negative regulation of cation channel activity (GO:2001258) | 2.53265556 |
| 93 | positive regulation of prostaglandin secretion (GO:0032308) | 2.52529498 |
| 94 | regulation of cellular amine metabolic process (GO:0033238) | 2.48618400 |
| 95 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.46753849 |
| 96 | regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108) | 2.44929399 |
| 97 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.44890415 |
| 98 | positive regulation of defense response to virus by host (GO:0002230) | 2.44536960 |
| 99 | granulocyte activation (GO:0036230) | 2.43819320 |
| 100 | positive regulation of cell cycle arrest (GO:0071158) | 2.42306629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.96546004 |
| 2 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 6.60716141 |
| 3 | VDR_22108803_ChIP-Seq_LS180_Human | 3.85199598 |
| 4 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.80336447 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.51696815 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.40735995 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.21997122 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.06308497 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.92804617 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.80860474 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.54020014 |
| 12 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.05120103 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.95234372 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.95202535 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.94889677 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.87773457 |
| 17 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84770847 |
| 18 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80085208 |
| 19 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.79730020 |
| 20 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.75481797 |
| 21 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.73587616 |
| 22 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.70009233 |
| 23 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.68494362 |
| 24 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.63384603 |
| 25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.59974197 |
| 26 | MYB_26560356_Chip-Seq_TH2_Human | 1.56500309 |
| 27 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.48671613 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.48090114 |
| 29 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.44082154 |
| 30 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.38261561 |
| 31 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.34823751 |
| 32 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.33832671 |
| 33 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.33781458 |
| 34 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.33606784 |
| 35 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33417737 |
| 36 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.32927668 |
| 37 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.32254719 |
| 38 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.25113484 |
| 39 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.21956653 |
| 40 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.14657027 |
| 41 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.13971744 |
| 42 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.13146442 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12986967 |
| 44 | AR_20517297_ChIP-Seq_VCAP_Human | 1.11669288 |
| 45 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.10203093 |
| 46 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.09776923 |
| 47 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.09776923 |
| 48 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.09754746 |
| 49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.08693587 |
| 50 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.06792621 |
| 51 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.06364036 |
| 52 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.04960081 |
| 53 | P300_27268052_Chip-Seq_Bcells_Human | 1.04631295 |
| 54 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.04054929 |
| 55 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.03669127 |
| 56 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.02803615 |
| 57 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.02565008 |
| 58 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.01725806 |
| 59 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.98929425 |
| 60 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98396845 |
| 61 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98396845 |
| 62 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.98321024 |
| 63 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.96778211 |
| 64 | GATA3_26560356_Chip-Seq_TH2_Human | 0.96580756 |
| 65 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.96296235 |
| 66 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.96191421 |
| 67 | MYB_26560356_Chip-Seq_TH1_Human | 0.95937318 |
| 68 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.95755867 |
| 69 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.95554973 |
| 70 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94969454 |
| 71 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.94312210 |
| 72 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.94205271 |
| 73 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.92196331 |
| 74 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.92045637 |
| 75 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91819534 |
| 76 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.91708196 |
| 77 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.91466533 |
| 78 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90676676 |
| 79 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.90266538 |
| 80 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89073168 |
| 81 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89021687 |
| 82 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88347146 |
| 83 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.86744169 |
| 84 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.86568152 |
| 85 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.84932626 |
| 86 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.84502075 |
| 87 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.84188569 |
| 88 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.82671900 |
| 89 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.82299436 |
| 90 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.82133536 |
| 91 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.81571855 |
| 92 | CBP_21632823_ChIP-Seq_H3396_Human | 0.80597536 |
| 93 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.79780086 |
| 94 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78796591 |
| 95 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.77763043 |
| 96 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.77093871 |
| 97 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.76936755 |
| 98 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.76174260 |
| 99 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75769232 |
| 100 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.75723533 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 3.91363526 |
| 2 | MP0004145_abnormal_muscle_electrophysio | 3.40783572 |
| 3 | MP0009785_altered_susceptibility_to | 2.74959123 |
| 4 | MP0003806_abnormal_nucleotide_metabolis | 2.66036736 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.49402069 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 2.38941981 |
| 7 | MP0002822_catalepsy | 2.38261392 |
| 8 | MP0000372_irregular_coat_pigmentation | 2.34233131 |
| 9 | MP0005464_abnormal_platelet_physiology | 2.27301836 |
| 10 | MP0003724_increased_susceptibility_to | 2.25229037 |
| 11 | MP0003646_muscle_fatigue | 2.01780896 |
| 12 | MP0002095_abnormal_skin_pigmentation | 1.99899449 |
| 13 | MP0005000_abnormal_immune_tolerance | 1.94699812 |
| 14 | MP0009764_decreased_sensitivity_to | 1.89870297 |
| 15 | MP0005083_abnormal_biliary_tract | 1.88391660 |
| 16 | MP0006072_abnormal_retinal_apoptosis | 1.85485474 |
| 17 | MP0005085_abnormal_gallbladder_physiolo | 1.85239309 |
| 18 | MP0001968_abnormal_touch/_nociception | 1.84086306 |
| 19 | MP0001905_abnormal_dopamine_level | 1.82252471 |
| 20 | MP0002723_abnormal_immune_serum | 1.79453591 |
| 21 | MP0004147_increased_porphyrin_level | 1.77531244 |
| 22 | MP0002277_abnormal_respiratory_mucosa | 1.75332009 |
| 23 | MP0009379_abnormal_foot_pigmentation | 1.74249672 |
| 24 | MP0004036_abnormal_muscle_relaxation | 1.69767266 |
| 25 | MP0004043_abnormal_pH_regulation | 1.68801140 |
| 26 | MP0000747_muscle_weakness | 1.66650937 |
| 27 | MP0001800_abnormal_humoral_immune | 1.65537335 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 1.63389579 |
| 29 | MP0002736_abnormal_nociception_after | 1.62050493 |
| 30 | MP0002837_dystrophic_cardiac_calcinosis | 1.61738205 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.57275335 |
| 32 | MP0000685_abnormal_immune_system | 1.53833187 |
| 33 | MP0003436_decreased_susceptibility_to | 1.51796130 |
| 34 | MP0005025_abnormal_response_to | 1.51594134 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.51306990 |
| 36 | MP0006082_CNS_inflammation | 1.50462167 |
| 37 | MP0001819_abnormal_immune_cell | 1.49050892 |
| 38 | MP0005670_abnormal_white_adipose | 1.47158826 |
| 39 | MP0003075_altered_response_to | 1.45709936 |
| 40 | MP0008872_abnormal_physiological_respon | 1.43772824 |
| 41 | MP0005646_abnormal_pituitary_gland | 1.42975981 |
| 42 | MP0000569_abnormal_digit_pigmentation | 1.42276239 |
| 43 | MP0002089_abnormal_postnatal_growth/wei | 1.31822892 |
| 44 | MP0002876_abnormal_thyroid_physiology | 1.31756431 |
| 45 | MP0010386_abnormal_urinary_bladder | 1.30014769 |
| 46 | MP0002102_abnormal_ear_morphology | 1.27100024 |
| 47 | MP0001542_abnormal_bone_strength | 1.25834735 |
| 48 | MP0000749_muscle_degeneration | 1.21122050 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.20636699 |
| 50 | MP0001545_abnormal_hematopoietic_system | 1.20636699 |
| 51 | MP0004510_myositis | 1.18589959 |
| 52 | MP0001790_abnormal_immune_system | 1.17771844 |
| 53 | MP0005387_immune_system_phenotype | 1.17771844 |
| 54 | MP0008789_abnormal_olfactory_epithelium | 1.17492804 |
| 55 | MP0008469_abnormal_protein_level | 1.16975471 |
| 56 | MP0005636_abnormal_mineral_homeostasis | 1.15837859 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.15111429 |
| 58 | MP0009765_abnormal_xenobiotic_induced | 1.15098576 |
| 59 | MP0002106_abnormal_muscle_physiology | 1.14903417 |
| 60 | MP0002419_abnormal_innate_immunity | 1.13352597 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.12954536 |
| 62 | MP0005166_decreased_susceptibility_to | 1.12173252 |
| 63 | MP0008875_abnormal_xenobiotic_pharmacok | 1.09723364 |
| 64 | MP0000230_abnormal_systemic_arterial | 1.07348168 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.06966467 |
| 66 | MP0000716_abnormal_immune_system | 1.06873292 |
| 67 | MP0002398_abnormal_bone_marrow | 1.06602003 |
| 68 | MP0000343_altered_response_to | 1.04747118 |
| 69 | MP0003045_fibrosis | 1.00733857 |
| 70 | MP0000759_abnormal_skeletal_muscle | 0.99625229 |
| 71 | MP0001919_abnormal_reproductive_system | 0.99430059 |
| 72 | MP0009763_increased_sensitivity_to | 0.99134027 |
| 73 | MP0000751_myopathy | 0.99055495 |
| 74 | MP0003638_abnormal_response/metabolism_ | 0.98347608 |
| 75 | MP0002269_muscular_atrophy | 0.97978988 |
| 76 | MP0003880_abnormal_central_pattern | 0.97908143 |
| 77 | MP0001765_abnormal_ion_homeostasis | 0.97265110 |
| 78 | MP0005084_abnormal_gallbladder_morpholo | 0.97220575 |
| 79 | MP0005360_urolithiasis | 0.97210966 |
| 80 | MP0002166_altered_tumor_susceptibility | 0.96719590 |
| 81 | MP0006036_abnormal_mitochondrial_physio | 0.96660125 |
| 82 | MP0005620_abnormal_muscle_contractility | 0.96507911 |
| 83 | MP0003866_abnormal_defecation | 0.96399434 |
| 84 | MP0004142_abnormal_muscle_tone | 0.94894816 |
| 85 | MP0003950_abnormal_plasma_membrane | 0.94821798 |
| 86 | MP0001970_abnormal_pain_threshold | 0.91495841 |
| 87 | MP0002735_abnormal_chemical_nociception | 0.87693731 |
| 88 | MP0001873_stomach_inflammation | 0.86005136 |
| 89 | MP0009745_abnormal_behavioral_response | 0.85894277 |
| 90 | MP0000858_altered_metastatic_potential | 0.85859642 |
| 91 | MP0002733_abnormal_thermal_nociception | 0.85105128 |
| 92 | MP0004947_skin_inflammation | 0.83511409 |
| 93 | MP0005165_increased_susceptibility_to | 0.82716512 |
| 94 | MP0002429_abnormal_blood_cell | 0.82314886 |
| 95 | MP0000750_abnormal_muscle_regeneration | 0.81194077 |
| 96 | MP0003763_abnormal_thymus_physiology | 0.80535236 |
| 97 | MP0006276_abnormal_autonomic_nervous | 0.80380603 |
| 98 | MP0001853_heart_inflammation | 0.79837399 |
| 99 | MP0003186_abnormal_redox_activity | 0.79180429 |
| 100 | MP0001663_abnormal_digestive_system | 0.77968099 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Palpebral edema (HP:0100540) | 4.33255339 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 4.31633812 |
| 3 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.11104702 |
| 4 | Mitochondrial inheritance (HP:0001427) | 3.95610432 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.93283971 |
| 6 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.65208533 |
| 7 | Progressive macrocephaly (HP:0004481) | 3.61574954 |
| 8 | Hepatocellular necrosis (HP:0001404) | 3.49243352 |
| 9 | Decreased circulating renin level (HP:0003351) | 3.42178709 |
| 10 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.41427069 |
| 11 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.41427069 |
| 12 | Acute encephalopathy (HP:0006846) | 3.28486247 |
| 13 | IgG deficiency (HP:0004315) | 3.14410485 |
| 14 | Hepatic necrosis (HP:0002605) | 3.09908269 |
| 15 | 3-Methylglutaconic aciduria (HP:0003535) | 3.08406343 |
| 16 | Decreased central vision (HP:0007663) | 3.07268991 |
| 17 | Increased CSF lactate (HP:0002490) | 3.04086538 |
| 18 | Nemaline bodies (HP:0003798) | 3.02446229 |
| 19 | Aplastic anemia (HP:0001915) | 3.02233504 |
| 20 | Hypoproteinemia (HP:0003075) | 2.86627348 |
| 21 | Acute hepatic failure (HP:0006554) | 2.79310455 |
| 22 | Increased intramyocellular lipid droplets (HP:0012240) | 2.78507801 |
| 23 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.70594997 |
| 24 | Oligomenorrhea (HP:0000876) | 2.69863517 |
| 25 | Delayed CNS myelination (HP:0002188) | 2.66343772 |
| 26 | Periorbital edema (HP:0100539) | 2.65944301 |
| 27 | Facial edema (HP:0000282) | 2.60959628 |
| 28 | T lymphocytopenia (HP:0005403) | 2.60801326 |
| 29 | Increased IgM level (HP:0003496) | 2.59828183 |
| 30 | Renal Fanconi syndrome (HP:0001994) | 2.54808527 |
| 31 | Round ear (HP:0100830) | 2.52453125 |
| 32 | Abnormality of T cell number (HP:0011839) | 2.45018322 |
| 33 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.43236874 |
| 34 | Hyperkalemia (HP:0002153) | 2.39795250 |
| 35 | Generalized aminoaciduria (HP:0002909) | 2.38907878 |
| 36 | Pendular nystagmus (HP:0012043) | 2.38011608 |
| 37 | Exercise intolerance (HP:0003546) | 2.37465626 |
| 38 | Cerebral edema (HP:0002181) | 2.36414970 |
| 39 | Muscle fiber inclusion bodies (HP:0100299) | 2.36393374 |
| 40 | Exertional dyspnea (HP:0002875) | 2.35322386 |
| 41 | Abnormality of the prostate (HP:0008775) | 2.34716029 |
| 42 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.34378656 |
| 43 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.32502098 |
| 44 | Optic disc pallor (HP:0000543) | 2.32497245 |
| 45 | Disinhibition (HP:0000734) | 2.30196535 |
| 46 | Mask-like facies (HP:0000298) | 2.29066939 |
| 47 | Distal arthrogryposis (HP:0005684) | 2.27291715 |
| 48 | Attenuation of retinal blood vessels (HP:0007843) | 2.25297840 |
| 49 | Type I transferrin isoform profile (HP:0003642) | 2.23634511 |
| 50 | Stomatitis (HP:0010280) | 2.22691856 |
| 51 | Chronic bronchitis (HP:0004469) | 2.22052202 |
| 52 | Congenital, generalized hypertrichosis (HP:0004540) | 2.21942762 |
| 53 | Increased hepatocellular lipid droplets (HP:0006565) | 2.20555288 |
| 54 | Toxemia of pregnancy (HP:0100603) | 2.19512678 |
| 55 | Myopathic facies (HP:0002058) | 2.19395475 |
| 56 | Increased muscle lipid content (HP:0009058) | 2.19379225 |
| 57 | Absent phalangeal crease (HP:0006109) | 2.05732464 |
| 58 | Keratoconus (HP:0000563) | 2.04600616 |
| 59 | Increased corneal curvature (HP:0100692) | 2.04600616 |
| 60 | Cerebral palsy (HP:0100021) | 2.03846784 |
| 61 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.01662918 |
| 62 | Emotional lability (HP:0000712) | 2.00663581 |
| 63 | Reduced antithrombin III activity (HP:0001976) | 1.98139279 |
| 64 | Prolonged neonatal jaundice (HP:0006579) | 1.97527104 |
| 65 | Congenital stationary night blindness (HP:0007642) | 1.96947608 |
| 66 | Gastrointestinal infarctions (HP:0005244) | 1.96680674 |
| 67 | Lactic acidosis (HP:0003128) | 1.96656606 |
| 68 | Joint swelling (HP:0001386) | 1.95345367 |
| 69 | Type 2 muscle fiber atrophy (HP:0003554) | 1.93861427 |
| 70 | X-linked dominant inheritance (HP:0001423) | 1.93596913 |
| 71 | Exercise-induced myalgia (HP:0003738) | 1.92205607 |
| 72 | Amyotrophic lateral sclerosis (HP:0007354) | 1.91819743 |
| 73 | Respiratory failure (HP:0002878) | 1.91634088 |
| 74 | Hypokalemic alkalosis (HP:0001949) | 1.91619809 |
| 75 | Erythema (HP:0010783) | 1.91107527 |
| 76 | Myotonia (HP:0002486) | 1.90894988 |
| 77 | Purpura (HP:0000979) | 1.90030947 |
| 78 | Pulmonary infiltrates (HP:0002113) | 1.87820783 |
| 79 | Lipid accumulation in hepatocytes (HP:0006561) | 1.85209240 |
| 80 | Abnormal spermatogenesis (HP:0008669) | 1.84051556 |
| 81 | Mediastinal lymphadenopathy (HP:0100721) | 1.83883623 |
| 82 | Hypokalemia (HP:0002900) | 1.83285285 |
| 83 | Hyperactive renin-angiotensin system (HP:0000841) | 1.83167601 |
| 84 | Retinal dysplasia (HP:0007973) | 1.82564089 |
| 85 | Poor speech (HP:0002465) | 1.82211484 |
| 86 | Chronic diarrhea (HP:0002028) | 1.82031455 |
| 87 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.81884274 |
| 88 | Hepatosplenomegaly (HP:0001433) | 1.81502662 |
| 89 | Abnormality of alanine metabolism (HP:0010916) | 1.81068947 |
| 90 | Hyperalaninemia (HP:0003348) | 1.81068947 |
| 91 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.81068947 |
| 92 | Vasculitis (HP:0002633) | 1.80432882 |
| 93 | Increased serum lactate (HP:0002151) | 1.80373302 |
| 94 | Intrahepatic cholestasis (HP:0001406) | 1.79962352 |
| 95 | Epistaxis (HP:0000421) | 1.77009672 |
| 96 | Muscle fiber atrophy (HP:0100295) | 1.75820584 |
| 97 | Encephalitis (HP:0002383) | 1.74935033 |
| 98 | Metabolic acidosis (HP:0001942) | 1.74769499 |
| 99 | Constricted visual fields (HP:0001133) | 1.74563197 |
| 100 | Petechiae (HP:0000967) | 1.74356820 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TESK2 | 4.90527335 |
| 2 | NME2 | 4.20236380 |
| 3 | TESK1 | 3.97473180 |
| 4 | LIMK1 | 3.33519189 |
| 5 | KDR | 3.15613317 |
| 6 | MAP3K12 | 2.97499517 |
| 7 | TXK | 2.87092259 |
| 8 | BMPR2 | 2.52002956 |
| 9 | SCYL2 | 2.38003325 |
| 10 | VRK2 | 2.33156661 |
| 11 | TAOK3 | 2.13140740 |
| 12 | PIM2 | 2.08419656 |
| 13 | PHKG2 | 2.06231780 |
| 14 | PHKG1 | 2.06231780 |
| 15 | BCKDK | 1.97560723 |
| 16 | ARAF | 1.92264193 |
| 17 | MST4 | 1.91213986 |
| 18 | ADRBK2 | 1.79181736 |
| 19 | LMTK2 | 1.41916410 |
| 20 | MYLK | 1.40306950 |
| 21 | TIE1 | 1.37770986 |
| 22 | GRK7 | 1.36658046 |
| 23 | MAPKAPK3 | 1.34292235 |
| 24 | RIPK4 | 1.33229860 |
| 25 | TLK1 | 1.31352014 |
| 26 | MAP4K2 | 1.28548888 |
| 27 | OBSCN | 1.20655602 |
| 28 | ERBB3 | 1.20146459 |
| 29 | MAP3K11 | 1.19422028 |
| 30 | WNK4 | 1.18078823 |
| 31 | TNK2 | 1.15847616 |
| 32 | CDK19 | 1.15546234 |
| 33 | DAPK1 | 1.11526059 |
| 34 | MAP4K1 | 1.04771356 |
| 35 | CSNK1G3 | 1.04503961 |
| 36 | MAP2K7 | 0.99689228 |
| 37 | CSF1R | 0.96631570 |
| 38 | STK16 | 0.95530401 |
| 39 | NUAK1 | 0.94537036 |
| 40 | CSNK1G2 | 0.92758610 |
| 41 | CAMKK2 | 0.91173396 |
| 42 | VRK1 | 0.88621484 |
| 43 | STK39 | 0.87857354 |
| 44 | GRK1 | 0.87715632 |
| 45 | CSNK1A1L | 0.84000869 |
| 46 | ITK | 0.83180185 |
| 47 | TEC | 0.81537095 |
| 48 | MATK | 0.81529404 |
| 49 | CSNK1G1 | 0.80291299 |
| 50 | SYK | 0.80167857 |
| 51 | MAPK13 | 0.79504048 |
| 52 | AURKA | 0.78758038 |
| 53 | DAPK2 | 0.74600881 |
| 54 | GRK6 | 0.74592134 |
| 55 | JAK3 | 0.74121406 |
| 56 | IKBKB | 0.73517478 |
| 57 | MOS | 0.71419140 |
| 58 | ABL2 | 0.68575346 |
| 59 | ILK | 0.66934791 |
| 60 | PINK1 | 0.64943877 |
| 61 | TAOK2 | 0.64444336 |
| 62 | INSRR | 0.64061977 |
| 63 | OXSR1 | 0.64053854 |
| 64 | CSK | 0.64022980 |
| 65 | ADRBK1 | 0.63374964 |
| 66 | DAPK3 | 0.61626417 |
| 67 | ZAK | 0.60995253 |
| 68 | RPS6KA5 | 0.59757047 |
| 69 | FES | 0.55718573 |
| 70 | GRK5 | 0.54086216 |
| 71 | MUSK | 0.53887539 |
| 72 | MINK1 | 0.53288816 |
| 73 | TBK1 | 0.51777604 |
| 74 | ROCK1 | 0.51617128 |
| 75 | CCNB1 | 0.51155853 |
| 76 | PAK1 | 0.48914206 |
| 77 | DYRK2 | 0.45700157 |
| 78 | IKBKE | 0.45498064 |
| 79 | TRPM7 | 0.44656525 |
| 80 | PRKCQ | 0.43691696 |
| 81 | CAMK2G | 0.43671722 |
| 82 | BMX | 0.41359847 |
| 83 | ZAP70 | 0.40872038 |
| 84 | PIK3CG | 0.40669644 |
| 85 | PIM1 | 0.40021254 |
| 86 | LYN | 0.37074528 |
| 87 | PRKCE | 0.36773066 |
| 88 | PRKACA | 0.36520313 |
| 89 | MAP3K3 | 0.36511255 |
| 90 | BMPR1B | 0.33758794 |
| 91 | BLK | 0.32522307 |
| 92 | CDK8 | 0.31810920 |
| 93 | LCK | 0.30919132 |
| 94 | BTK | 0.29601528 |
| 95 | PRKCA | 0.29332288 |
| 96 | CSNK1A1 | 0.28367769 |
| 97 | PKN1 | 0.26093736 |
| 98 | FYN | 0.25168986 |
| 99 | EPHB2 | 0.24017519 |
| 100 | FLT3 | 0.23984860 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.58034764 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.77346091 |
| 3 | Asthma_Homo sapiens_hsa05310 | 3.22229332 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.20246923 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.04001940 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.03023432 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 3.01240511 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.53282243 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.48878769 |
| 10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.48531399 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.38776822 |
| 12 | Alzheimers disease_Homo sapiens_hsa05010 | 2.31290381 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.17952289 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 2.03788067 |
| 15 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.97902536 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.96237575 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.95212694 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.90138800 |
| 19 | Protein export_Homo sapiens_hsa03060 | 1.83858214 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.80872950 |
| 21 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.65779581 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.62333479 |
| 23 | Viral myocarditis_Homo sapiens_hsa05416 | 1.61755620 |
| 24 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.59134757 |
| 25 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.58747152 |
| 26 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.36038739 |
| 27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.28354993 |
| 28 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.27042031 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.26521590 |
| 30 | Salivary secretion_Homo sapiens_hsa04970 | 1.18910046 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.11889103 |
| 32 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.09043144 |
| 33 | Salmonella infection_Homo sapiens_hsa05132 | 1.08057001 |
| 34 | RNA polymerase_Homo sapiens_hsa03020 | 1.01829703 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01024809 |
| 36 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.98024475 |
| 37 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.96551113 |
| 38 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96002679 |
| 39 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.92750449 |
| 40 | Phototransduction_Homo sapiens_hsa04744 | 0.92748839 |
| 41 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83762966 |
| 42 | Leishmaniasis_Homo sapiens_hsa05140 | 0.83638118 |
| 43 | Morphine addiction_Homo sapiens_hsa05032 | 0.83107909 |
| 44 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.81619197 |
| 45 | Olfactory transduction_Homo sapiens_hsa04740 | 0.81073733 |
| 46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.80768490 |
| 47 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78031710 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.77582189 |
| 49 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.75366522 |
| 50 | Legionellosis_Homo sapiens_hsa05134 | 0.74208116 |
| 51 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.64783012 |
| 52 | Phagosome_Homo sapiens_hsa04145 | 0.63709734 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63148137 |
| 54 | Mineral absorption_Homo sapiens_hsa04978 | 0.62137169 |
| 55 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.61884534 |
| 56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.61791517 |
| 57 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.61374138 |
| 58 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.60200186 |
| 59 | Tuberculosis_Homo sapiens_hsa05152 | 0.58823467 |
| 60 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58092188 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.57857262 |
| 62 | Purine metabolism_Homo sapiens_hsa00230 | 0.57629906 |
| 63 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.57577868 |
| 64 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.56525123 |
| 65 | Measles_Homo sapiens_hsa05162 | 0.55486746 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55201883 |
| 67 | Endocytosis_Homo sapiens_hsa04144 | 0.52742603 |
| 68 | GABAergic synapse_Homo sapiens_hsa04727 | 0.51362034 |
| 69 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49604733 |
| 70 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.47748215 |
| 71 | Sulfur relay system_Homo sapiens_hsa04122 | 0.47639236 |
| 72 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.45265564 |
| 73 | Taste transduction_Homo sapiens_hsa04742 | 0.43198457 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.42950011 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.41849529 |
| 76 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41340339 |
| 77 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40762786 |
| 78 | Peroxisome_Homo sapiens_hsa04146 | 0.40739496 |
| 79 | RNA degradation_Homo sapiens_hsa03018 | 0.39784886 |
| 80 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.38253027 |
| 81 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.38238470 |
| 82 | Tight junction_Homo sapiens_hsa04530 | 0.36951025 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.35616037 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.35420347 |
| 85 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34319684 |
| 86 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34014192 |
| 87 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.33233701 |
| 88 | Influenza A_Homo sapiens_hsa05164 | 0.31397956 |
| 89 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31106955 |
| 90 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.30853180 |
| 91 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30163672 |
| 92 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.29369122 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28344501 |
| 94 | Retinol metabolism_Homo sapiens_hsa00830 | 0.24915477 |
| 95 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.24785366 |
| 96 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24099997 |
| 97 | Circadian rhythm_Homo sapiens_hsa04710 | 0.21862061 |
| 98 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.20665478 |
| 99 | Circadian entrainment_Homo sapiens_hsa04713 | 0.20648365 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.20037028 |

